Methvin Isaac
36Patents
8h-index
78Co-inventors
78Inventor score
Filing activity: Jun 29, 1999 → May 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6660753B2 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | Chemistry; Metallurgy | 115 | Expired |
| US7112595B2 | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | Chemistry; Metallurgy | 63 | Expired |
| US7485722B2 | Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators | Chemistry; Metallurgy | 28 | Active |
| US7585881B2 | Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | Chemistry; Metallurgy | 24 | Active |
| US7074809B2 | Compounds | Chemistry; Metallurgy | 18 | Expired |
| US7960422B2 | Pharmaceutically active compounds containing tetrazolyl and triazolyl rings | Chemistry; Metallurgy | 9 | Active |
| US6166072A | Amino acid derivatives | Chemistry; Metallurgy | 8 | Expired |
| US7868008B2 | Substituted isoindolones and their use as metabotropic glutamate receptor potentiators | Chemistry; Metallurgy | 8 | Expired |
| US6380242B1 | N-alkylamino-indoles for the treatment of migraine | Human Necessities | 7 | Expired |
| US7456200B2 | Compounds | Chemistry; Metallurgy | 5 | Expired |
| US7968570B2 | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators | Chemistry; Metallurgy | 4 | Active |
| US7799792B2 | Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 | Chemistry; Metallurgy | 4 | Active |
| US6103743A | Unsaturated amino acid derivatives | Chemistry; Metallurgy | 4 | Expired |
| US6716837B1 | Heterocyclic compounds for the treatment of migraine | Chemistry; Metallurgy | 3 | Expired |
| US8377940B2 | Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 | Chemistry; Metallurgy | 3 | Active |
| US7476684B2 | Compounds for the treatment of neurological, psychiatric or pain disorders | Human Necessities | 3 | Active |
| US6897215B1 | Compounds having 5-HT6 receptor antagonist activity | Chemistry; Metallurgy | 2 | Expired |
| US11518764B2 | Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction | Human Necessities | 2 | Active |
| US7807706B2 | Metabotropic glutamate-receptor-potentiating isoindolones | Chemistry; Metallurgy | 2 | Expired |
| US11174250B2 | Substituted carboxamides as inhibitors of WDR5 protein-protein binding | Chemistry; Metallurgy | 2 | Active |
| US11505539B2 | Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders | Chemistry; Metallurgy | 2 | Active |
| US7678796B2 | MGluR5 modulators I | Chemistry; Metallurgy | 1 | Active |
| US11319299B2 | Substituted carboxamides as inhibitors of WDR5 protein-protein binding | Human Necessities | 1 | Active |
| US7576077B2 | Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists | Chemistry; Metallurgy | 1 | Expired |
| US11242351B2 | Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.